Kanya Rajangam - Oct 16, 2023 Form 4 Insider Report for Turnstone Biologics Corp. (TSBX)

Role
Director
Signature
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
Stock symbol
TSBX
Transactions as of
Oct 16, 2023
Transactions value $
$0
Form type
4
Date filed
10/17/2023, 06:41 PM
Previous filing
Jul 20, 2023
Next filing
Feb 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSBX Stock Option (Right to Buy) Award $0 +8.01K $0.00 8.01K Oct 16, 2023 Common Stock 8.01K $2.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the date of the first annual general meeting of stockholders occurring after October 12, 2023, subject to the Reporting Person's continuous service through each such vesting date.